

"Global bio-infrastructure platform accelerating the impact of health advancements"
Hurdle builds diagnostic infrastructure that enables healthcare providers, digital health companies, and research institutions to launch and scale lab testing globally. The platform integrates sample collection, laboratory networks, data pipelines, and AI-driven biomarker discovery into a single system. Hurdle manages the operational, regulatory, and technical complexity so innovators can focus on science. Founded by Cambridge and Oxford scientists, Hurdle combines expertise in epigenetics and multi-omics with a compliance-first platform. Clients use the infrastructure to power clinical trials, consumer health programmes, and biomarker development. Over three million tests have been processed across UKAS-accredited laboratories.


33
Team Members
2017
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where diagnostic breakthroughs reach patients without decades of delay, enabling precision medicine at scale and transforming health outcomes through accessible, rapid, and scientifically validated testing infrastructure.
Hurdle empowers individuals to take control of their health by providing clinically validated lab tests that can be easily initiated and collected from home, making the health benefits of biological testing accessible to more people.